Isaac Odeyemi

2.1k total citations
76 papers, 1.5k citations indexed

About

Isaac Odeyemi is a scholar working on Urology, Epidemiology and Rheumatology. According to data from OpenAlex, Isaac Odeyemi has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Urology, 28 papers in Epidemiology and 27 papers in Rheumatology. Recurrent topics in Isaac Odeyemi's work include Urinary Bladder and Prostate Research (28 papers), Pelvic floor disorders treatments (27 papers) and Urinary Tract Infections Management (21 papers). Isaac Odeyemi is often cited by papers focused on Urinary Bladder and Prostate Research (28 papers), Pelvic floor disorders treatments (27 papers) and Urinary Tract Infections Management (21 papers). Isaac Odeyemi collaborates with scholars based in United Kingdom, Netherlands and France. Isaac Odeyemi's co-authors include Zalmaï Hakimi, John Nixon, Jameel Nazir, Samuel Aballéa, Helen Dakin, Gorden Muduma, Khaled Maman, Nancy Devlin, Oliver A. Cornely and Richard F. Pollock and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Urology.

In The Last Decade

Isaac Odeyemi

72 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isaac Odeyemi United Kingdom	22	556	527	476	221	221	76	1.5k
Parvin Tajik Iran	18	175 0.3×	181 0.3×	91 0.2×	55 0.2×	111 0.5×	54	1.0k
Alisa J. Stephens‐Shields United States	14	204 0.4×	124 0.2×	116 0.2×	35 0.2×	103 0.5×	70	708
Maria Haller Austria	21	188 0.3×	40 0.1×	24 0.1×	76 0.3×	65 0.3×	60	1.4k
Jat Sandhu Canada	18	278 0.5×	17 0.0×	59 0.1×	72 0.3×	107 0.5×	42	1.5k
Suneeta Mittal India	25	302 0.5×	28 0.1×	111 0.2×	17 0.1×	144 0.7×	123	3.0k
Mario Festin Philippines	26	491 0.9×	25 0.0×	55 0.1×	45 0.2×	56 0.3×	51	1.8k
Patrick Moran Ireland	18	182 0.3×	33 0.1×	60 0.1×	74 0.3×	140 0.6×	40	837
Anna Kowalczyk Poland	15	260 0.5×	48 0.1×	269 0.6×	61 0.3×	43 0.2×	54	911
William Murk United States	23	428 0.8×	28 0.1×	131 0.3×	68 0.3×	104 0.5×	46	2.2k
Luigi Napolitano Italy	21	425 0.8×	169 0.3×	122 0.3×	9 0.0×	115 0.5×	103	1.5k

Countries citing papers authored by Isaac Odeyemi

Since Specialization

Citations

This map shows the geographic impact of Isaac Odeyemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isaac Odeyemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isaac Odeyemi more than expected).

Fields of papers citing papers by Isaac Odeyemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isaac Odeyemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isaac Odeyemi. The network helps show where Isaac Odeyemi may publish in the future.

Co-authorship network of co-authors of Isaac Odeyemi

This figure shows the co-authorship network connecting the top 25 collaborators of Isaac Odeyemi. A scholar is included among the top collaborators of Isaac Odeyemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isaac Odeyemi. Isaac Odeyemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Odeyemi, Isaac, et al.. (2025). Selenium-biofortified Gboma (Solanum macrocarpon L.) vegetable-supplemented diets increased circulating selenium levels and potentiated endogenous anti-inflammatory, antioxidant and immunomodulatory properties in Wistar rats. BioMetals. 38(6). 1827–1840.

Toumi, Mondher, Ruth Pulikottil-Jacob, Kara Watts, Isaac Odeyemi, & Karin M. Butler. (2025). An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting. Infectious Diseases and Therapy. 14(6). 1265–1276. 1 indexed citations

Bell, DJ, Carol-Anne Duthie, Colin Mason, et al.. (2024). Developing a tool to assess the health-related quality of life in calves with respiratory disease: tool refinement and construct validity testing. animal. 18(11). 101215–101215. 1 indexed citations

Watt, Maureen, et al.. (2017). "De-escalation" strategy using micafungin for the treatment of systemic <em>Candida</em> infections: budget impact in France and Germany. ClinicoEconomics and Outcomes Research. Volume 9. 763–774. 4 indexed citations

Muduma, Gorden, Isaac Odeyemi, & Richard F. Pollock. (2015). Evaluating The Economic Implications of Nonadherence And Antibody-Mediated Rejection In Renal Transplant Recipients: The Role of Once-Daily, Prolonged-Release Tacrolimus In The Uk Setting. Value in Health. 18(3). A187–A187. 2 indexed citations

Berni, Ellen, et al.. (2014). Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm: Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation. Value in Health. 17(3). A224–A224. 3 indexed citations

Mathias, Susan D., Ross D. Crosby, Jameel Nazir, et al.. (2014). Validation of the Patient Perception of Intensity of Urgency Scale in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. Value in Health. 17(8). 823–829. 10 indexed citations

Herdman, Michael, Marco Pavesi, Nancy Devlin, et al.. (2014). Using Eq-5d-3l And Oab-5d To Assess Changes In Health-Related Quality Of Life (Hrqol) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph). Value in Health. 17(3). A295–A295.

Kelleher, Con, et al.. (2014). Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk. Value in Health. 17(7). A469–A469. 3 indexed citations

10.

Pollock, Richard F., Gorden Muduma, Isaac Odeyemi, & Jayne Smith‐Palmer. (2014). Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence. Patient Preference and Adherence. 8. 391–391. 13 indexed citations

11.

Mathias, Susan D., Ross D. Crosby, Monique Klaver, et al.. (2013). The patient perception of intensity of urgency scale (PPIUS): Its validation in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Value in Health. 16(3). A37–A37. 1 indexed citations

12.

Pollock, Richard F., Jayne Smith‐Palmer, Isaac Odeyemi, & Gorden Muduma. (2013). An Analysis of the Cost of Switching Renal Transplant Patients from an Immediate-Release to a Prolonged-Release Formulation of Tacrolimus Based on Differences in Trough Concentration Variability in the United Kingdom. Value in Health. 16(7). A631–A631. 1 indexed citations

13.

Trueman, David, et al.. (2013). Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom. Value in Health. 16(7). A383–A383. 1 indexed citations

14.

Odeyemi, Isaac, et al.. (2013). The Association Between Severity of ‘Average’ Pain (NPRS) and the EQ-5D Index in Patients with Neuropathic Pain. Value in Health. 16(7). A386–A386. 1 indexed citations

15.

Hakimi, Zalmaï, Susan D. Mathias, Ross D. Crosby, Isaac Odeyemi, & Jameel Nazir. (2013). Defining clinically meaningful changes for the patient perception of intensity of urgency scale (PPIUS) in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Value in Health. 16(3). A40–A40. 2 indexed citations

16.

Odeyemi, Isaac & John Nixon. (2013). Assessing equity in health care through the national health insurance schemes of Nigeria and Ghana: a review-based comparative analysis. International Journal for Equity in Health. 12(1). 9–9. 112 indexed citations

17.

Sidhu, Manpreet, et al.. (2011). PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries. Value in Health. 14(7). A452–A453. 1 indexed citations

18.

Cornely, Oliver A., et al.. (2008). Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany. Current Medical Research and Opinion. 24(6). 1743–1753. 37 indexed citations

19.

Currie, Craig J., et al.. (2006). The impact of the overactive bladder on health‐related utility and quality of life. British Journal of Urology. 97(6). 1267–1272. 52 indexed citations

20.

Dakin, Helen, Nancy Devlin, & Isaac Odeyemi. (2005). “Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making. Health Policy. 77(3). 352–367. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact